These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32100489)

  • 1. In reply: the evaluation of IgG titers' stability from blood samples is necessary.
    Ouh YT; Lee JK
    J Gynecol Oncol; 2020 Mar; 31(2):e44. PubMed ID: 32100489
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
    Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin concentrations in cervical mucus in patients with normal and abnormal cervical cytology.
    Coughlan BM; Skinner GR
    Br J Obstet Gynaecol; 1977 Feb; 84(2):129-34. PubMed ID: 843479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Reply.
    Dorton BJ; Vitonis AF; Feldman S
    Obstet Gynecol; 2016 Jan; 127(1):163. PubMed ID: 26695568
    [No Abstract]   [Full Text] [Related]  

  • 5. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia.
    Mendis LN; Best JM; Banatvala JE
    Int J Cancer; 1981 May; 27(5):669-77. PubMed ID: 6270022
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions.
    Sasagawa T; Yamazaki H; Dong YZ; Satake S; Tateno M; Inoue M
    Int J Cancer; 1998 Feb; 75(4):529-35. PubMed ID: 9466652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuation of immunoglobulin levels in cervical mucus during the various phases of female reproductive life and its alteration in uterine disorders.
    Saha K; Bhatia G; Mukherjee S; Mitra AB; Luthra UK
    Indian J Med Res; 1981 Nov; 74():696-704. PubMed ID: 7341447
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.
    Van Doorslaer K; Reimers LL; Studentsov YY; Einstein MH; Burk RD
    Gynecol Oncol; 2010 Feb; 116(2):208-12. PubMed ID: 19555999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress and cervical dysplasia.
    De Punzio C; Salvestroni C; Guazzelli G; Papa MC; Freschi G; Ferdeghini M; Masoni S
    Eur J Gynaecol Oncol; 1998; 19(3):287-90. PubMed ID: 9641233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes.
    Costa AP; Giraldo PC; Cobucci RN; Consolaro ML; Souza RP; Canário LB; Machado PR; Randall Martins R; Vieira Baptista P; Jr JE; Gonçalves AK
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2799-2804. PubMed ID: 32986383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Author's reply to: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
    Vaccarella S; Clifford GM; Howell-Jones R; Snijders PJ; Franceschi S;
    Int J Cancer; 2011 Sep; 129(5):1283-5. PubMed ID: 21080437
    [No Abstract]   [Full Text] [Related]  

  • 12. IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia.
    Matsumoto K; Yasugi T; Oki A; Fujii T; Nagata C; Sekiya S; Hoshiai H; Taketani Y; Kanda T; Kawana T; Yoshikawa H
    Cancer Lett; 2006 Jan; 231(2):309-13. PubMed ID: 16399232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids.
    Sasagawa T; Rose RC; Azar KK; Sakai A; Inoue M
    Int J Cancer; 2003 Apr; 104(3):328-35. PubMed ID: 12569556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin-containing plasma cells recruited to cervical neoplasia.
    Edwards RP; Pitts A; Crowley-Nowick P; Partridge EE; Gore H; Mestecky J
    Obstet Gynecol; 1996 Apr; 87(4):520-6. PubMed ID: 8602302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
    J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic vaccination using HPV 16 E7 to eradicate CIN3.
    Tewari KS
    J Gynecol Oncol; 2019 Nov; 30(6):e119. PubMed ID: 31576704
    [No Abstract]   [Full Text] [Related]  

  • 17. Exfoliative immunocytology of cervical carcinoma.
    Efthymiou CJ; Smulewicz JJ
    Arch Pathol Lab Med; 1977 Nov; 101(11):575-8. PubMed ID: 334107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Stukart MJ; Robbesom AA; von Blomberg-van der Flier BM; Herbrink P; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    Int J Cancer; 1996 Dec; 68(6):731-8. PubMed ID: 8980175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus (HPV) vaccines: prospects for eradicating cervical cancer.
    Stanley MA
    J Fam Plann Reprod Health Care; 2004 Oct; 30(4):213-5. PubMed ID: 15530217
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.